Esther Dyson (@edyson) is executive founder of Wellville (@WaytoWellville), a 10-year project to improve health care. A longtime tech analyst and investor, Esther is now exploring the etiology of addiction and the path to both individual and institutional behavior change.
Separately, she is an active investor in health-related startups, including in 23andMe (formerly a director), 4D Healthware, Basil Health, Big Health, Boundless.ai, CareMESH, Clover Health, Devoted Health, Doppel, Eligible, Enso Relief, Epistemic.ai, Ezra.com, Hawthorne Effect, HealthCelerate, HealthTap, i2Dx, MealShare, Medesk, MedicaSafe, mEquilibrium, Nanowear, NeuroGeneCES, Nuna, Omada Health, PatientsLikeMe/iCarbonX, PatientsKnowBest, Prognos.ai, Proofpilot, Resilient, Sapiens DS, Solera (also an advisor), StartupHealth, Supportiv, Syllable.ai, Tega Pharmaceutical, Tocagen, Trusty.care, Turbine.ai, Valkee, Virgo, X-VAX and Zipongo.
She also trained as a backup cosmonaut in Star City outside Moscow Russia. While there she had the pleasure of spending time not only with the cosmonauts, but also with some of the US’s finest astronauts. Dyson began her career as a fact-checker for Forbes Magazine, and spent five years on Wall Street as a securities analyst. From 1983 to 2006, at EDventure Holdings, she produced the newsletter Release 1.0 and ran PC Forum, the computer industry’s leading annual conference. She sold EDventure to CNET in 2005, and left in 2007. In 1997 she published her first book, Release 2.0, about the impact of the internet on individuals’ lives. She speaks English and Russian and a little French and German, and has a degree in economics from Harvard.